FindTrial
Sign In

Etoposide (VP-16)

DRUG6 trials

Sponsors

M.D. Anderson Cancer Center, Dana-Farber Cancer Institute, Nanfang Hospital, Southern Medical University, The University of Hong Kong

Conditions

Autologous Hematopoietic Stem Cell TransplantationConditioningDiffuse Large B-cell LymphomaEwings SarcomaLymphomaMultiple MyelomaNatural Killer/T-Cell Lymphoma, Nasal and Nasal-TypeNeuroblastoma

Phase 2

Intensive Chemo-Radiotherapy With Peripheral Blood Progenitor Cell Rescue for Children With Advanced Neuroblastoma and Sarcomas
CompletedNCT00165139
Dana-Farber Cancer InstituteEwings Sarcoma, Neuroblastoma, Non-rhabdomyosarcoma Soft Tissue Sarcoma
Start: 1996-01-31End: 2009-02-28Updated: 2009-11-02
BUCY+VP-16 vs BUCY Conditioning Regimen for DLBCL Undergoing Auto-HSCT
NCT03229616
Nanfang Hospital, Southern Medical UniversityAutologous Hematopoietic Stem Cell Transplantation, Conditioning, Diffuse Large B-cell Lymphoma
Start: 2017-07-05End: 2020-06-30Target: 122Updated: 2017-10-12
Mel vs BUCY+VP-16 Conditioning Regimen for MM Undergoing Auto-HSCT
NCT03385096
Nanfang Hospital, Southern Medical UniversityAutologous Hematopoietic Stem Cell Transplantation, Conditioning, Multiple Myeloma
Start: 2018-01-02End: 2021-12-31Target: 122Updated: 2020-02-25
BUCYE Conditioning Regimen for PCNSL Undergoing Auto-HSCT
NCT03733327
Nanfang Hospital, Southern Medical UniversityAutologous Hematopoietic Stem Cell Transplantation, Conditioning, Primary Central Nervous System Lymphoma
Start: 2018-11-30End: 2021-10-31Target: 20Updated: 2018-11-07

Phase 3

Combination Chemotherapy in Treating Patients With Lymphoma
CompletedNCT00002835
M.D. Anderson Cancer CenterLymphoma
Start: 1995-10-30End: 2004-02-04Updated: 2018-11-15
SIMPLE Chemotherapy for NK Lymphoma/Leukaemia
NCT03623087
The University of Hong KongNatural Killer/T-Cell Lymphoma, Nasal and Nasal-Type, Non-Hodgkin's Lymphoma, Relapsed, Non-Hodgkin T-cell Lymphoma
Start: 2017-07-01End: 2020-06-30Target: 68Updated: 2018-08-14